Sima Lev
Affiliations: | Weizmann Institute of Science, Rehovot, Israel |
Area:
Cell signaling, Membrane trafficking, Cancer biologyGoogle:
"Sima Lev"Parents
Sign in to add mentorYosef Yarden | grad student | 1989-1994 | Weizmann Institute |
Joseph Schlessinger | post-doc | 1994-1998 | NYU Med School (Neurotree) |
Children
Sign in to add traineeNili Dahan | grad student | Weizmann Institute | |
Orly Laufman | grad student | Weizmann Institute | |
Vladimir Litvak | grad student | Weizmann Institute |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Vinik Y, Maimon A, Dubey V, et al. (2024) Programming a Ferroptosis-to-Apoptosis Transition Landscape Revealed Ferroptosis Biomarkers and Repressors for Cancer Therapy. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2307263 |
Gil-Henn H, Girault JA, Lev S. (2023) PYK2, a hub of signaling networks in breast cancer progression. Trends in Cell Biology |
Nataraj NB, Noronha A, Lee JS, et al. (2022) Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors. Cell Reports. 38: 110418 |
Müller AK, Köhler UA, Trzebanski S, et al. (2022) Mouse Modeling Dissecting Macrophage-Breast Cancer Communication Uncovered Roles of PYK2 in Macrophage Recruitment and Breast Tumorigenesis. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2105696 |
Castellanet O, Ahmad F, Vinik Y, et al. (2021) BCL-XL blockage in TNBC models confers vulnerability to inhibition of specific cell cycle regulators. Theranostics. 11: 9180-9197 |
Khera L, Lev S. (2021) Accelerating AXL targeting for TNBC therapy. The International Journal of Biochemistry & Cell Biology. 106057 |
Khera L, Vinik Y, Maina F, et al. (2021) The AXL-PYK2-PKCα axis as a nexus of stemness circuits in TNBC. Life Science Alliance. 4 |
Lamballe F, Ahmad F, Vinik Y, et al. (2021) Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 8: 2003049 |
Vinik Y, Ortega FG, Mills GB, et al. (2020) Proteomic analysis of circulating extracellular vesicles identifies potential markers of breast cancer progression, recurrence, and response. Science Advances. 6 |
Verma N, Vinik Y, Saroha A, et al. (2020) Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis. Science Advances. 6 |